NbN C&A
Published by:
European College of Neuropsychopharmacology (ECNP)
Description
N/A
Screenshots
Loading...
Please wait..
NbN C&A FAQ
-
Is NbN C&A free?
Yes, NbN C&A is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is NbN C&A legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does NbN C&A cost?
NbN C&A is free.
-
What is NbN C&A revenue?
To get estimated revenue of NbN C&A app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Switzerland yet.
Ratings History
NbN C&A Reviews
No Reviews in Switzerland
App doesn't have any reviews in Switzerland yet.
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
|
Chart
|
Category
|
Rank
|
|---|---|---|
|
Top Free
|
|
441
|
NbN C&A Installs
Last 30 days
NbN C&A Revenue
Last 30 daysNbN C&A Revenue and Downloads
Gain valuable insights into NbN C&A performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Languages
- English
- Recent release
- 3.1.1 (1 year ago )
- Released on
- May 8, 2017 (7 years ago )
- Also available in
- United States , Brazil , Russia , Poland , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , Kazakhstan , Romania , Sweden , Singapore , Türkiye , Ukraine , South Africa , Egypt , Austria , Australia , Azerbaijan , Canada , Switzerland , Chile , Colombia , Dominican Republic , Ecuador , Argentina , Spain , Greece , Hungary , Indonesia , Israel , India , Italy , South Korea
- Last Updated
- 2 weeks ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.